Login / Signup

A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer.

Yanan WangZhenhua GaoWen ZhaoHongxin LiXue MengJisheng Li
Published in: Thoracic cancer (2024)
The addition of TRT during the pre-emptive no progression phase was associated with a significantly longer PFS than during the delayed slow progression phase and had an acceptable safety profile. Our results might support the earlier initiation of TRT after induction therapy for some patients with driver-gene-negative mNSCLC.
Keyphrases
  • copy number
  • genome wide
  • squamous cell carcinoma
  • early stage
  • genome wide identification
  • small cell lung cancer
  • spinal cord
  • radiation therapy
  • locally advanced
  • gene expression
  • transcription factor